Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
STROCompany Name
SUTRO BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSUTRO BIOPHARMA INC - Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
STRO - ROIC Historical data
| Date | Invested Capital | Net Income Common Stock | Return on Invested Capital |
|---|---|---|---|
| 6/30/2025 | $ -12.52M | $ -208.7M | 0% |
| 3/31/2025 | $ -4.41M | $ -245.22M | 0% |
| 12/31/2024 | $ 67.75M | $ -227.46M | -335.71% |
| 9/30/2024 | $ 136.08M | $ -123.95M | -91.09% |
| 6/30/2024 | $ 178.7M | $ -124.45M | -69.64% |
| 3/31/2024 | $ 126.09M | $ -114.96M | -91.17% |
| 12/31/2023 | $ 183.28M | $ -106.79M | -58.27% |
| 9/30/2023 | $ 150.52M | $ -172.45M | -114.57% |
| 6/30/2023 | $ 197.37M | $ -142.66M | -72.28% |
| 3/31/2023 | $ 231.98M | $ -130.14M | -56.1% |
Key Performance Insights, Last 5 Years
- SUTRO BIOPHARMA INC's latest trailing twelve months (TTM) ROIC stands at 4.7%.
- Over the past 5 years, SUTRO BIOPHARMA INC's average ROIC has been -65.6%.
- The median ROIC for SUTRO BIOPHARMA INC during this period was -47.64%
- SUTRO BIOPHARMA INC reached its highest ROIC over the past 5 years at 4.7%.
- The lowest ROIC recorded by SUTRO BIOPHARMA INC in the same timeframe -335.71%
SUTRO BIOPHARMA INC's ROIC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROIC Benchmarks
Similar metrics to ROIC:
- Cash Return on Invested Capital - [Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
Definition of Return on Invested Capital
[Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].Net Inc. Cmn. / Inv. Capital
(=) ROIC ROIC for SUTRO BIOPHARMA INC is calculated as follows: Net Inc. Cmn. [ $ 12.63M ] / Inv. Capital [ $ 268.53M ]
(=) ROIC [ 4.7% ] STRO - Return on Invested Capital, Last 5 years
-335.71%
Minimum
Dec 31, 2024
4.7%
Maximum
Sep 30, 2020
-65.6%
Average
-47.64%
Median
ROIC Benchmark AnalysisMarket
The chart above depicts the distribution of ROIC for companies in the Total Stock Market. The average ROIC of the companies is 0.69% with a standard deviation of 15.18%.
The following table provides additional summary stats:
ROIC in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | -46.36% |
| max | 48.66% |
| average | 0.69% |
| median | 3.38% |
| std | 15.18% |